文献速递主动脉疾病

预防性主动脉分支栓塞预防II型内漏的系统综述与荟萃分析

Systematic review and meta-analysis of prophylactic aortic side branch embolization to prevent type II endoleaks.
PubMed 文献 · J Vasc Surg · 2020-05-19

该系统综述与荟萃分析检索至2019年3月,纳入13项回顾性队列研究共1427例患者,比较预防性栓塞与标准EVAR。结果显示预防性栓塞与较低的瘤囊增大率、II型内漏发生率和再干预率相关,但缺乏随机试验,存在选择偏倚和残余混杂。

要点

  • 预防性栓塞组II型内漏发生率18.5% vs 对照组38.6%(OR 0.34,95%CI 0.26-0.44)。
  • 预防性栓塞组再干预率1.5% vs 对照组12.4%(OR 0.12,95%CI 0.06-0.24)。
  • 瘤囊增大频率7.4% vs 13.4%(OR 0.54,95%CI 0.29-1),差异无统计学意义。

核心结论

  • 预防性主动脉分支栓塞可能降低瘤囊增大、II型内漏发生率和再干预率,但证据质量有限。

研究设计与样本

  • 系统综述与荟萃分析,遵循PRISMA指南,检索MEDLINE和Scopus至2019年3月。
  • 纳入13项回顾性队列研究,共1427例患者,比较预防性栓塞与标准EVAR,无随机试验。

主要发现

  • 5项研究报告瘤囊增大,栓塞组7.4%(14/90)vs 对照组13.4%,OR 0.54(95%CI 0.29-1)。
  • II型内漏率栓塞组18.5%(100/540)vs 对照组38.6%(342/887),OR 0.34(95%CI 0.26-0.44)。
  • 基于10项研究,再干预率栓塞组1.5%(7/468)vs 对照组12.4%(80/646),OR 0.12(95%CI 0.06-0.24)。
  • 9项研究显示肠系膜下动脉和腰动脉栓塞的技术成功率分别为82.3%和69.1%。
  • 一项研究中10/108例(9.3%)栓塞后出现非特异性腹痛,均经 overnight 补液缓解;1例既往右半结肠切除患者死于肠系膜下动脉栓塞后缺血性结肠炎。

临床怎么用

  • 预防性栓塞可能作为降低EVAR术后II型内漏及相关再干预的策略,但需个体化评估。
  • 鉴于缺乏高质量证据,不应常规开展预防性栓塞,应等待前瞻性随机试验结果。

局限性

  • 仅纳入回顾性队列研究,可能存在选择偏倚和残余混杂。
  • 缺乏随机对照试验,无法确定因果关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Type II endoleaks are the most common type of endoleak after endovascular aneurysm repair (EVAR) and may cause late sac expansion and rupture. To prevent this, prophylactic embolization of aortic side branches has been suggested. The aim of this review was to assess the current evidence for this prophylactic treatment and its association with sac size enlargement as well as rate of and reintervention for type II endoleak. METHODS: This was a systematic review and meta-analysis following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The MEDLINE and Scopus databases were used to search for related articles until March 2019. After screening, original studies reporting outcome comparing patients having prophylactic embolization with those undergoing EVAR without prophylactic embolization were included. An assessment of the quality of the included studies as well as data extraction was performed by two independent observers. Statistical analysis was performed using Review Manager 5.3 (The Nordic Cochrane Center, Copenhagen, Denmark). RESULTS: There were 3777 publications identified. After elimination of duplicate entries and review of titles and abstracts, 13 retrospective cohort studies including 1427 patients comparing prophylactic embolization with standard EVAR therapy were identified. No randomized trials were available. Five of these 13 studies reported sac growth, with a frequency of 7.4% (14/90) in the embolization group vs 13.4% in controls (odds ratio [OR], 0.54; 95% confidence interval [CI], 0.29-1). The rate of type II endoleak was 18.5% (100/540) in the embolization group vs 38.6% in the control group (342/887; OR, 0.34; 95% CI, 0.26-0.44). Based on 10 studies, the rate of reintervention was 1.5% (7/468) in the embolization group vs 12.4% (80/646) in the control group (OR, 0.12; 95% CI, 0.06-0.24). Nine of these 13 studies showed that technical success of inferior mesenteric artery and lumbar artery embolization was 82.3% and 69.1%, respectively. Regarding complications, 10 of 108 patients (9.3%) in one study reported nonspecific abdominal pain after embolization, and all resolved with overnight rehydration. Only one patient, who previously had right hemicolectomy, died after inferior mesenteric artery embolization of ischemic colitis. CONCLUSIONS: This systematic review and meta-analysis suggests that prophylactic aortic side branch embolization may be associated with lower rate of sac enlargement, incidence of type II endoleaks, and reinterventions. However, high-quality unbiased studies are lacking in this field, and this review and meta-analysis may be affected by selection bias and residual confounders remaining in the retrospective studies. To conclude whether prophylactic embolization should be routinely performed, a prospective, randomized trial is required.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yu HYH, Lindström D, Wanhainen A, et al. Systematic review and meta-analysis of prophylactic aortic side branch embolization to prevent type II endoleaks. J Vasc Surg. 2020. PMID: 32442608. doi:10.1016/j.jvs.2020.05.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。